By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Neurotrope 

10732 Hawk’s Vista Street

Plantation  Florida  33324  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
Neurotrope Announces Publication Demonstrating Synaptic Regeneration With The PKC Epsilon Activator Bryostatin, In A Fragile X Disease Late Brain Development Model 3/8/2016 6:54:42 AM
Neurotrope Chief Scientific Officer To Present Keynote Address At Sachs Associates’ 1st Annual Neuroscience Biopartnering & Investment Forum 2/23/2016 8:10:25 AM
Neurotrope Announces Changes To Board Of Directors 2/19/2016 7:22:44 AM
Neurotrope CSO To Participate In Alzheimer’s Panel At 18th Annual Neurotrope CEO & Investor Conference 2/9/2016 1:15:44 PM
Neurotrope Announces $15.3 Million Private Placement 11/16/2015 9:31:44 AM
Neurotrope To Conduct Study On Niemann-Pick Type C, A Devastating Rare Pediatric Disease 6/24/2015 6:43:23 AM
Neurotrope To Present Findings Of In-Vitro Studies Of Bryostatin's Effects On Niemann Pick Type C1 Cells At The Annual "Michael, Marcia & Christa Parseghian Scientific Conference" For Niemann-Pick Type C 6/12/2015 6:51:44 AM
Neurotrope Joins National Organization for Rare Disorders (NORD) Corporate Council 4/24/2015 12:12:15 PM
Neurotrope Receives Research Grant From The FRAXA Research Foundation To Fund Pre-Clinical Fragile X Syndrome Behavioral Studies 4/20/2015 10:46:36 AM
Neurotrope Receives FDA Orphan Drug Designation For Bryostatin In The Treatment Of Fragile X Syndrome 4/9/2015 6:20:23 AM
1234
//-->